Bio-Rad Laboratories (BIO) Other financing activities (2009 - 2024)

Bio-Rad Laboratories (BIO) reported Other financing activities of $600000.0 for Q1 2024, up 2042.86% quarter-over-quarter from $28000.0 in Q3 2019.

Bio-Rad Laboratories (BIO) Other financing activities (2009 - 2024) Analysis & Trends

Bio-Rad Laboratories (BIO) has 10 years of Other financing activities data on file, last reported at $600000.0 in Q1 2024.

Other financing activities for Q1 2024 came in at $600000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $600000.0 (changed N/A YoY), and the FY2024 annual result was $600000.0, changed N/A from the prior year.
Other financing activities improved to $600000.0 in Q1 2024 per BIO's latest filing, from $28000.0 in the prior quarter.
Over five years, Other financing activities peaked at $600000.0 in Q1 2024 and troughed at $600000.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Bio-Rad Laboratories	7.62 Bn	6.05 Bn	309.40 Mn

Download Data